8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis

      other
      , MD, , MD
      Annals of Internal Medicine
      American College of Physicians

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          COVID-19 could cause infection in persons with opioid use disorder, increase opioid overdose rates, reverse system-level gains in expanding access to medication for opioid use disorder, halt critical research, and prevent exacting legal reparations against opioid manufacturers. The authors call for urgent action to counteract these risks.

          Related collections

          Most cited references3

          • Record: found
          • Abstract: not found
          • Book: not found

          Medications for Opioid Use Disorder Save Lives

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Abuses of FDA Regulatory Procedures — The Case of Suboxone

                Bookmark

                Author and article information

                Journal
                Ann Intern Med
                Ann. Intern. Med
                aim
                Annals of Internal Medicine
                American College of Physicians
                0003-4819
                1539-3704
                2 April 2020
                : M20-1210
                Affiliations
                [1 ]VA Connecticut Healthcare System, West Haven, Connecticut, and Yale Program in Addiction Medicine and Yale School of Medicine, New Haven, Connecticut (W.C.B.)
                [2 ]Yale Program in Addiction Medicine and Yale School of Medicine, New Haven, Connecticut (D.A.F.)
                Article
                aim-olf-M201210
                10.7326/M20-1210
                7138333
                32240291
                9a911ce4-0f0a-411b-9087-b3413a99dacb
                Copyright @ 2020

                This article is made available via the PMC Open Access Subset for unrestricted re-use for research, analyses, and text and data mining through PubMed Central. Acknowledgement of the original source shall include a notice similar to the following: "© 2020 American College of Physicians. Some rights reserved. This work permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited." These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                Categories
                Ideas and Opinions

                Comments

                Comment on this article